08.02.2013 07:50 Uhr, Quelle: Wallstreet online

MorphoSys Receives First Patent on Novel Antibody Platform Ylanthia in the US

MorphoSys AG / MorphoSys Receives First Patent on Novel Antibody Platform Ylanthia in the US . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. MorphoSys AG (FSE: MOR; Prime …

Weiterlesen bei Wallstreet online